Skip to main content
. Author manuscript; available in PMC: 2015 Jun 24.
Published in final edited form as: Anesthesiology. 2009 Mar;110(3):638–647. doi: 10.1097/ALN.0b013e318195b51d

Table 1.

Summary of Clonidine–Dexmedetomidine Antinociceptive Interactions

Probe Drug, Intrathecal, nmol ED50 Clonidine
(95% CI)
ED50
Dexmedetomidine
(95% CI)
Interaction
Figure 1, ICR mice Single drug 3.0 (2.1–3.9) 3.8 (1.3–6.3)
Clonidine–dexmedetomidine, 1:1 ratio Synergistic
  Observed combination 0.0045 (0.0001–0.0183)*
  Theoretical additive 1.7 (1.3–2.1)
Figure 2, α2AAR-WT Single drug 1.2 (0.45–1.9) 1.0 (0.43–1.7)
Clonidine–dexmedetomidine, 1:1 ratio Synergistic
  Observed combination 0.18 (0.1–0.26)*
  Theoretical additive 0.54 (0.34–0.74)
Figures 4A and B, α2CAR-WT Single drug 1.7 (1.3–2.1) 1.9 (1.3–2.5)
Clonidine–dexmedetomidine, 1:1 ratio Synergistic
  Observed combination 0.16 (0.11–0.23)*
  Theoretical additive 0.90 (0.73–1.1)
Figures 4C and D, α2CAR-zKO Single drug 5.3 (4.1–6.5) 4.4 (3.5–5.3)
Clonidine–dexmedetomidine, 1:1 ratio Subadditive
  Observed combination 3.6 (2.2–5.0)*
  Theoretical additive 1.71 (1.3–2.1)
*

Significant difference from theoretical additive by Student t test, P < 0.05.

AR = adrenergic receptor; CI = confidence interval; ICR = Institute of Cancer Research; KO = knockout; WT = wild type.